<p class="MsoNormal">The global <span style="mso-bidi-font-weight: bold;">Lab Automation Market</span> is entering a decisive growth phase as life sciences, diagnostics, and chemical research organizations accelerate digital transformation and high-throughput workflows. According to the latest findings from Kings Research, demand for automated instruments, robotics, informatics platforms, and integrated workflow solutions is rising across pharma/biotech R&D, clinical diagnostics, CROs, academia, and industrial QA/QC. Momentum is being fueled by the need to boost reproducibility, reduce turnaround time, address skilled-labor shortages, and enhance data integrity from sample to result.

<p class="MsoNormal">This press release provides an executive-ready overview of market growth dynamics, emerging trends, demand pockets, segmentation, key players, and regional opportunities&mdash;crafted for strategy leaders, product owners, and corporate communications teams preparing investor briefings, stakeholder updates, and media outreach.

<p class="MsoNormal">The global lab automation market size was valued at USD 7.23 billion in 2024 and is projected to grow from USD 7.64 billion in 2025 to USD 11.79 billion by 2032, exhibiting a CAGR of 6.40% during the forecast period.

<p class="MsoNormal">Market Growth Snapshot

<p class="MsoNormal">The Lab Automation Market continues to expand on the back of three converging forces: the maturation of enabling technologies (robotics, vision, microfluidics, AI), sustained investment in drug discovery and precision diagnostics, and the steady migration toward closed-loop, data-driven lab operations. Organizations are moving beyond point solutions to end-to-end automated workflows that combine sample preparation, liquid handling, incubation, detection, and analytics&mdash;underpinned by interoperable informatics.

<p class="MsoNormal"><strong style="mso-bidi-font-weight: normal;">Unlock Key Growth Opportunities: https://www.kingsresearch.com/lab-automation-market-2454

<p class="MsoNormal">List of Key Companies in Lab Automation Market:

<ul style="margin-top: 0cm;" type="disc">
<li class="MsoNormal" style="mso-list: l10 level1 lfo16; tab-stops: list 36.0pt;">Thermo Fisher Scientific Inc.</li>
<li class="MsoNormal" style="mso-list: l10 level1 lfo16; tab-stops: list 36.0pt;">Danaher Corporation</li>
<li class="MsoNormal" style="mso-list: l10 level1 lfo16; tab-stops: list 36.0pt;">Tecan Group Ltd.</li>
<li class="MsoNormal" style="mso-list: l10 level1 lfo16; tab-stops: list 36.0pt;">Agilent Technologies Inc.</li>
<li class="MsoNormal" style="mso-list: l10 level1 lfo16; tab-stops: list 36.0pt;">PerkinElmer, Inc.</li>
<li class="MsoNormal" style="mso-list: l10 level1 lfo16; tab-stops: list 36.0pt;">Siemens</li>
<li class="MsoNormal" style="mso-list: l10 level1 lfo16; tab-stops: list 36.0pt;">Hudson Lab Automation</li>
<li class="MsoNormal" style="mso-list: l10 level1 lfo16; tab-stops: list 36.0pt;">Beckman Coulter, Inc.</li>
<li class="MsoNormal" style="mso-list: l10 level1 lfo16; tab-stops: list 36.0pt;">BD</li>
<li class="MsoNormal" style="mso-list: l10 level1 lfo16; tab-stops: list 36.0pt;">Eppendorf SE</li>
<li class="MsoNormal" style="mso-list: l10 level1 lfo16; tab-stops: list 36.0pt;">Hoffmann-La Roche Ltd</li>
<li class="MsoNormal" style="mso-list: l10 level1 lfo16; tab-stops: list 36.0pt;">Abbott</li>
<li class="MsoNormal" style="mso-list: l10 level1 lfo16; tab-stops: list 36.0pt;">BIOM&Eacute;RIEUX</li>
<li class="MsoNormal" style="mso-list: l10 level1 lfo16; tab-stops: list 36.0pt;">Brooks Automation, Inc.</li>
<li class="MsoNormal" style="mso-list: l10 level1 lfo16; tab-stops: list 36.0pt;">Opentrons</li>
</ul>
<p class="MsoNormal">Growth Catalysts at a Glance

<ul style="margin-top: 0cm;" type="disc">
<li class="MsoNormal" style="mso-list: l8 level1 lfo1; tab-stops: list 36.0pt;">Rising throughput requirements in drug discovery, omics, bioprocessing, and clinical testing.</li>
<li class="MsoNormal" style="mso-list: l8 level1 lfo1; tab-stops: list 36.0pt;">Chronic disease burden and precision medicine programs expanding test menus and sample volumes.</li>
<li class="MsoNormal" style="mso-list: l8 level1 lfo1; tab-stops: list 36.0pt;">Workforce scarcity and ergonomic/safety priorities driving robot adoption for repetitive, hazardous, or delicate tasks.</li>
<li class="MsoNormal" style="mso-list: l8 level1 lfo1; tab-stops: list 36.0pt;">Regulatory focus on data integrity (ALCOA+) and auditability encouraging digital, traceable workflows.</li>
<li class="MsoNormal" style="mso-list: l8 level1 lfo1; tab-stops: list 36.0pt;">Cloud-native LIMS/ELN and API-first software enabling scalable multi-site deployments.</li>
<li class="MsoNormal" style="mso-list: l8 level1 lfo1; tab-stops: list 36.0pt;">Capital reallocation toward modular, flexible automation that preserves future upgrade paths.</li>
</ul>
<p class="MsoNormal">Demand Dynamics & Strategic Drivers

<p class="MsoNormal">Why stakeholders are investing now

<ul style="margin-top: 0cm;" type="disc">
<li class="MsoNormal" style="mso-list: l7 level1 lfo2; tab-stops: list 36.0pt;">Speed-to-Insight: Automated sample-to-answer workflows compress cycle times across HTS, NGS library prep, cell culture, and immunoassays&mdash;improving program velocity.</li>
<li class="MsoNormal" style="mso-list: l7 level1 lfo2; tab-stops: list 36.0pt;">Quality & Reproducibility: Precision liquid handling and standardized protocols reduce variability, elevating data confidence for regulatory submissions and tech transfer.</li>
<li class="MsoNormal" style="mso-list: l7 level1 lfo2; tab-stops: list 36.0pt;">Total Cost of Ownership (TCO): While CapEx can be significant, OpEx savings from lower reagent use, higher instrument utilization, and fewer reruns improve ROI.</li>
<li class="MsoNormal" style="mso-list: l7 level1 lfo2; tab-stops: list 36.0pt;">Scalability: Platform automation supports multi-shift operations and can scale across therapeutic areas, test types, and geographies.</li>
<li class="MsoNormal" style="mso-list: l7 level1 lfo2; tab-stops: list 36.0pt;">Digital Compliance: Integrated audit trails, e-signatures, and chain-of-custody simplify inspections and enable near real-time quality oversight.</li>
</ul>
<p class="MsoNormal">Key Restraints and Challenges

<ul style="margin-top: 0cm;" type="disc">
<li class="MsoNormal" style="mso-list: l1 level1 lfo3; tab-stops: list 36.0pt;">Upfront Costs & Change Management: Budget cycles and user adoption can slow rollouts without strong ROI cases and training.</li>
<li class="MsoNormal" style="mso-list: l1 level1 lfo3; tab-stops: list 36.0pt;">Integration Complexity: Interfacing legacy LIMS/ELN, instruments, and analytics can be non-trivial without standards-based middleware.</li>
<li class="MsoNormal" style="mso-list: l1 level1 lfo3; tab-stops: list 36.0pt;">Validation Burden: Regulated environments require rigorous validation and documentation for each change to automated workflows.</li>
<li class="MsoNormal" style="mso-list: l1 level1 lfo3; tab-stops: list 36.0pt;">Space & Utilities: Retrofitting constrained labs for robotics, ventilation, and noise mitigation requires planning.</li>
</ul>
<p class="MsoNormal">Opportunity Hotspots

<ul style="margin-top: 0cm;" type="disc">
<li class="MsoNormal" style="mso-list: l5 level1 lfo4; tab-stops: list 36.0pt;">Mid-market labs seeking pre-validated, &ldquo;automation-in-a-box&rdquo; solutions.</li>
<li class="MsoNormal" style="mso-list: l5 level1 lfo4; tab-stops: list 36.0pt;">Decentralized and satellite labs adopting compact benchtop robotics with cloud informatics.</li>
<li class="MsoNormal" style="mso-list: l5 level1 lfo4; tab-stops: list 36.0pt;">Single-use bioprocessing and automated upstream/downstream analytics.</li>
<li class="MsoNormal" style="mso-list: l5 level1 lfo4; tab-stops: list 36.0pt;">AI-assisted protocol optimization for liquid classes, deck layouts, and error prediction.</li>
<li class="MsoNormal" style="mso-list: l5 level1 lfo4; tab-stops: list 36.0pt;">Sustainability (lower reagent volumes, energy-efficient instruments, waste minimization).</li>
</ul>
<p class="MsoNormal">Market Trends Shaping the Forecast Period

<ul style="margin-top: 0cm;" type="disc">
<li class="MsoNormal" style="mso-list: l15 level1 lfo5; tab-stops: list 36.0pt;">Modular & Configurable Platforms: Swappable decks, interchangeable grippers, and protocol libraries help users reconfigure workflows quickly.</li>
<li class="MsoNormal" style="mso-list: l15 level1 lfo5; tab-stops: list 36.0pt;">No-Code / Low-Code Programming: Drag-and-drop protocol builders reduce barriers for biologists and technologists to create or adjust methods.</li>
<li class="MsoNormal" style="mso-list: l15 level1 lfo5; tab-stops: list 36.0pt;">Interoperability First: Vendors are exposing open APIs, OPC-UA/MQTT messaging, and adopting data standards (e.g., AnIML, SiLA) for plug-and-play integration.</li>
<li class="MsoNormal" style="mso-list: l15 level1 lfo5; tab-stops: list 36.0pt;">Closed-Loop Automation: Real-time QC and machine vision inform feedback loops (e.g., auto-rerun, dynamic pipetting corrections).</li>
<li class="MsoNormal" style="mso-list: l15 level1 lfo5; tab-stops: list 36.0pt;">Edge + Cloud Architecture: On-deck edge compute handles latency-sensitive control; cloud LIMS/ELN manages orchestration, audit trails, and analytics at scale.</li>
<li class="MsoNormal" style="mso-list: l15 level1 lfo5; tab-stops: list 36.0pt;">Human-Centric Design: Collaborative robots (cobots), safer enclosures, and UX-focused HMIs improve adoption and reduce training overhead.</li>
<li class="MsoNormal" style="mso-list: l15 level1 lfo5; tab-stops: list 36.0pt;">Microfluidics & Miniaturization: Nanoliter dispensing and microplate innovations cut reagent costs and expand assay menus.</li>
<li class="MsoNormal" style="mso-list: l15 level1 lfo5; tab-stops: list 36.0pt;">AI/ML Everywhere: Assay anomaly detection, predictive maintenance, and digital twins optimize uptime and capacity planning.</li>
<li class="MsoNormal" style="mso-list: l15 level1 lfo5; tab-stops: list 36.0pt;">Data Fabric for the Lab: Unified identity, metadata harmonization, and knowledge graphs streamline FAIR data practices.</li>
</ul>
<p class="MsoNormal">Segmentation Analysis

<p class="MsoNormal">By Product & Solution

<ul style="margin-top: 0cm;" type="disc">
<li class="MsoNormal" style="mso-list: l14 level1 lfo6; tab-stops: list 36.0pt;"><span style="mso-bidi-font-weight: bold;">Automated Liquid Handling Systems</span></li>
<li class="MsoNormal" style="mso-list: l14 level1 lfo6; tab-stops: list 36.0pt;"><span style="mso-bidi-font-weight: bold;">Automation-Ready Instruments</span></li>
<li class="MsoNormal" style="mso-list: l14 level1 lfo6; tab-stops: list 36.0pt;"><span style="mso-bidi-font-weight: bold;">Robotic Systems & Cobots</span></li>
<li class="MsoNormal" style="mso-list: l14 level1 lfo6; tab-stops: list 36.0pt;"><span style="mso-bidi-font-weight: bold;">Sample Management & Storage</span></li>
<li class="MsoNormal" style="mso-list: l14 level1 lfo6; tab-stops: list 36.0pt;"><span style="mso-bidi-font-weight: bold;">Informatics & Software</span></li>
<li class="MsoNormal" style="mso-list: l14 level1 lfo6; tab-stops: list 36.0pt;"><span style="mso-bidi-font-weight: bold;">Consumables & Accessories</span></li>
</ul>
<p class="MsoNormal">By Application

<ul style="margin-top: 0cm;" type="disc">
<li class="MsoNormal" style="mso-list: l9 level1 lfo7; tab-stops: list 36.0pt;"><span style="mso-bidi-font-weight: bold;">Drug Discovery & Development</span></li>
<li class="MsoNormal" style="mso-list: l9 level1 lfo7; tab-stops: list 36.0pt;"><span style="mso-bidi-font-weight: bold;">Genomics & Proteomics</span></li>
<li class="MsoNormal" style="mso-list: l9 level1 lfo7; tab-stops: list 36.0pt;"><span style="mso-bidi-font-weight: bold;">Clinical Diagnostics</span></li>
<li class="MsoNormal" style="mso-list: l9 level1 lfo7; tab-stops: list 36.0pt;"><span style="mso-bidi-font-weight: bold;">Bioprocessing & Cell/Gene Therapy</span></li>
<li class="MsoNormal" style="mso-list: l9 level1 lfo7; tab-stops: list 36.0pt;"><span style="mso-bidi-font-weight: bold;">Forensics, Food & Environmental Testing</span></li>
<li class="MsoNormal" style="mso-list: l9 level1 lfo7; tab-stops: list 36.0pt;"><span style="mso-bidi-font-weight: bold;">Academic & Government Research</span></li>
</ul>
<p class="MsoNormal">By Automation Type

<ul style="margin-top: 0cm;" type="disc">
<li class="MsoNormal" style="mso-list: l11 level1 lfo8; tab-stops: list 36.0pt;"><span style="mso-bidi-font-weight: bold;">Modular Benchtop Automation</span></li>
<li class="MsoNormal" style="mso-list: l11 level1 lfo8; tab-stops: list 36.0pt;"><span style="mso-bidi-font-weight: bold;">Workcell / Integrated Systems</span></li>
<li class="MsoNormal" style="mso-list: l11 level1 lfo8; tab-stops: list 36.0pt;"><span style="mso-bidi-font-weight: bold;">Collaborative & Mobile Robotics</span></li>
<li class="MsoNormal" style="mso-list: l11 level1 lfo8; tab-stops: list 36.0pt;"><span style="mso-bidi-font-weight: bold;">High-Throughput Screening Platforms</span></li>
</ul>
<p class="MsoNormal">By End User

<ul style="margin-top: 0cm;" type="disc">
<li class="MsoNormal" style="mso-list: l0 level1 lfo9; tab-stops: list 36.0pt;"><span style="mso-bidi-font-weight: bold;">Pharma & Biotech</span></li>
<li class="MsoNormal" style="mso-list: l0 level1 lfo9; tab-stops: list 36.0pt;"><span style="mso-bidi-font-weight: bold;">Clinical/Diagnostic Labs & Hospitals</span></li>
<li class="MsoNormal" style="mso-list: l0 level1 lfo9; tab-stops: list 36.0pt;"><span style="mso-bidi-font-weight: bold;">CROs/CMOs/CDMOs</span></li>
<li class="MsoNormal" style="mso-list: l0 level1 lfo9; tab-stops: list 36.0pt;"><span style="mso-bidi-font-weight: bold;">Academic & Research Institutes</span></li>
<li class="MsoNormal" style="mso-list: l0 level1 lfo9; tab-stops: list 36.0pt;"><span style="mso-bidi-font-weight: bold;">Industrial & Applied Testing Labs</span></li>
</ul>
<p class="MsoNormal">Regional Analysis

<p class="MsoNormal">North America

<ul style="margin-top: 0cm;" type="disc">
<li class="MsoNormal" style="mso-list: l6 level1 lfo10; tab-stops: list 36.0pt;">Strong adoption in pharma/biotech hubs and reference labs.</li>
<li class="MsoNormal" style="mso-list: l6 level1 lfo10; tab-stops: list 36.0pt;">Focus on compliance, cybersecurity, and multi-site harmonization.</li>
<li class="MsoNormal" style="mso-list: l6 level1 lfo10; tab-stops: list 36.0pt;">Growing deployments in cell & gene therapy and decentralized diagnostics.</li>
</ul>
<p class="MsoNormal">Europe

<ul style="margin-top: 0cm;" type="disc">
<li class="MsoNormal" style="mso-list: l12 level1 lfo11; tab-stops: list 36.0pt;">Mature automation markets in the UK, Germany, Switzerland, and Nordics.</li>
<li class="MsoNormal" style="mso-list: l12 level1 lfo11; tab-stops: list 36.0pt;">Public-private research consortia drive shared facilities and standardization.</li>
<li class="MsoNormal" style="mso-list: l12 level1 lfo11; tab-stops: list 36.0pt;">High demand for interoperability and validation services.</li>
</ul>
<p class="MsoNormal">Asia Pacific

<ul style="margin-top: 0cm;" type="disc">
<li class="MsoNormal" style="mso-list: l13 level1 lfo12; tab-stops: list 36.0pt;">Fastest growth in China, Japan, South Korea, India, and Singapore.</li>
<li class="MsoNormal" style="mso-list: l13 level1 lfo12; tab-stops: list 36.0pt;">Local manufacturing expansion and investment in high-throughput genomics.</li>
</ul>
<p class="MsoNormal">Latin America

<ul style="margin-top: 0cm;" type="disc">
<li class="MsoNormal" style="mso-list: l4 level1 lfo13; tab-stops: list 36.0pt;">Gradual adoption in national reference labs and multinational pharma sites.</li>
<li class="MsoNormal" style="mso-list: l4 level1 lfo13; tab-stops: list 36.0pt;">Preference for modular and cost-effective solutions.</li>
</ul>
<p class="MsoNormal">Middle East & Africa

<ul style="margin-top: 0cm;" type="disc">
<li class="MsoNormal" style="mso-list: l2 level1 lfo14; tab-stops: list 36.0pt;">Targeted automation in centralized hospital labs and industrial testing.</li>
<li class="MsoNormal" style="mso-list: l2 level1 lfo14; tab-stops: list 36.0pt;">Government-backed infrastructure projects creating new opportunities.</li>
</ul>
<p class="MsoNormal">Bullet Summary

<ul style="margin-top: 0cm;" type="disc">
<li class="MsoNormal" style="mso-list: l3 level1 lfo15; tab-stops: list 36.0pt;">Drivers: Throughput, reproducibility, labor shortages, digital compliance, precision medicine.</li>
<li class="MsoNormal" style="mso-list: l3 level1 lfo15; tab-stops: list 36.0pt;">Trends: Modular platforms, low-code tools, interoperability, closed-loop automation, AI integration.</li>
<li class="MsoNormal" style="mso-list: l3 level1 lfo15; tab-stops: list 36.0pt;">Barriers: High CapEx, integration challenges, validation burden.</li>
<li class="MsoNormal" style="mso-list: l3 level1 lfo15; tab-stops: list 36.0pt;">Hot Segments: NGS prep, clinical pre-analytics, bioprocess analytics, cobots.</li>
<li class="MsoNormal" style="mso-list: l3 level1 lfo15; tab-stops: list 36.0pt;">Top Buyers: Pharma/biotech, diagnostics labs, CROs, academia, industrial testing.</li>
<li class="MsoNormal" style="mso-list: l3 level1 lfo15; tab-stops: list 36.0pt;">Regions: North America & Europe lead adoption; Asia Pacific fastest-growing.</li>
</ul>
<p class="MsoNormal">About Kings Research

<p class="MsoNormal">Kings Research delivers market intelligence and strategic advisory across healthcare, life sciences, chemicals, and technology domains. Its Lab Automation Market coverage spans adoption benchmarks, vendor analysis, technology roadmaps, and regulatory insights to help decision-makers invest confidently.